
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.02 | 0.02 | 0.00 |
Shares | 97.68 | 97.68 | 0.00 |
Other | 2.30 | 2.44 | 0.14 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.61 | 18.77 |
Price to Book | 4.72 | 4.27 |
Price to Sales | 5.08 | 2.29 |
Price to Cash Flow | 15.62 | 15.61 |
Dividend Yield | 1.25 | 1.18 |
5 Years Earnings Growth | 4.87 | 11.14 |
Number of long holdings: 173
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 12.96 | 191.22 | +1.43% | |
Amgen | US0311621009 | 10.32 | 303.58 | +0.76% | |
Gilead | US3755581036 | 9.10 | 114.23 | +1.06% | |
Krystal Biotech | US5011471027 | 6.37 | 152.08 | -0.54% | |
Alnylam | US02043Q1076 | 5.72 | 330.55 | +1.77% | |
Regeneron Pharma | US75886F1075 | 3.02 | 558.15 | -0.09% | |
Ascendis Pharma AS | US04351P1012 | 2.65 | 163.32 | -0.51% | |
argenx ADR | US04016X1019 | 2.58 | 598.79 | +0.60% | |
UCB | BE0003739530 | 2.14 | 185.05 | +3.47% | |
Insmed | US4576693075 | 1.77 | 105.00 | +3.19% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 665.84B | 6.20 | 19.70 | 13.63 | ||
Fidelity Contrafund | 153.33B | 11.81 | 28.39 | 16.00 | ||
Fidelity Total Market Index Instl b | 111.51B | 5.68 | 19.09 | 12.90 | ||
Fidelity International Index Inst | 64.89B | 20.59 | 16.23 | 6.71 | ||
Fidelity Blue Chip Growth | 64.78B | 4.18 | 29.97 | 17.91 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review